Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all synonyms
Human Polyclonal EPH Receptor A7 Primary Antibody for IHC (p), WB - ABIN391899
Holder, Klein: Eph receptors and ephrins: effectors of morphogenesis. in Development (Cambridge, England) 1999
Show all 5 Pubmed References
Human Monoclonal EPH Receptor A7 Primary Antibody for IHC, ELISA - ABIN969104
Rual, Venkatesan, Hao, Hirozane-Kishikawa, Dricot, Li, Berriz, Gibbons, Dreze, Ayivi-Guedehoussou, Klitgord, Simon, Boxem, Milstein, Rosenberg, Goldberg, Zhang, Wong, Franklin, Li, Albala, Lim et al.: Towards a proteome-scale map of the human protein-protein interaction network. ... in Nature 2005
Show all 2 Pubmed References
receptor phosphorylation of EphA7, at least in part, suppress prostate cancer tumor malignancy through targeting PI3K (show PIK3CA Antibodies)/Akt (show AKT1 Antibodies) signaling pathways.
these findings suggest that miR (show MLXIP Antibodies)-448 functioned as a tumor suppressor gene in the development of osteosarcoma through targeting EPHA7.
the interactions of EphA5/ephrinA5 and/or EphA7/ephrinA5 between HSPCs and BMSCs, independently and cooperatively, play a role in HSPC colony formation through the upregulation of GM-CSFR. Furthermore, the adhesion/migration of HSPCs appears to be mediated in part through the activation of Rac1.
We have demonstrated the physical association and cellular co-localization of EPHA7 and EPHA10 (show EPHA10 Antibodies) in breast carcinoma cells. The nuclear co-localization of these two receptors in invasive MDA-MB-231 cells suggests their involvement in transcriptional activation of genes involved in invasiveness.
Eph receptor A7 may have an important role in the pathogenesis of nonsmall cell lung cancer by regulating PTEN expression via thephosphatase and tensin (show TNS1 Antibodies) homolog/AKT (show AKT1 Antibodies) pathway.
Depletion of EphA7 remarkably inhibited the proliferation and invasion of Hep (show EPHB6 Antibodies)-2 and AMC-HN-8 cells in comparison to control and EphA7 siRNA negative control (NC)-transfected cells.
Authors observed that the extracellular region of the EphA7 receptor was critical for interacting with caspase-8 (show CASP8 Antibodies), whereas the cytoplasmic region of EphA7 was not.
miR (show MLXIP Antibodies)-137 is able to directly bind to the EPHA7 3'UTR (show UTS2R Antibodies) and negatively regulate the expression of EPHA7 in HUVECs.
MTDH (show MTDH Antibodies) and EphA7 are markers for metastasis and poor prognosis of gallbladder adenocarcinoma.
The expression of EphA7 and/or MTDH (show MTDH Antibodies) might be closely related to the carcinogenesis, progression, clinical biological behaviors and prognosis of gallbladder adenocarcinoma.
Data suggest BMI1 (show BMI1 Antibodies) overexpression as a novel mechanism leading to EphA7 inactivation via H3K27 trimethylation and DNA methylation (show HELLS Antibodies) by which BMI-1 (show BMI1 Antibodies) controls cell proliferation in the postnatal lateral ventricle wall.
The present study demonstrates that EphA7 receptors, despite their similar structure, have distinct in vivo effects on corticothalamic system projections into the ventrobasal complex /medial division of the posterior nuclear group.
Results suggest that EphA7 plays an important role in the developmental formation of cochlear innervation pattern through controlling spiral ganglion neuron fiber ontogeny
Truncated EPHA7 promotes cell reprogramming by inducing ERK (show EPHB2 Antibodies) activity reduction.
Data show the effects of genetic loss of ephrin-A5 (show EFNA5 Antibodies), Eph (show EPHA1 Antibodies) receptors EphA4 (show EPHA4 Antibodies), and EphA7 on the development of medulloblastoma tumors in the smoothened (Smo) transgenic mouse model.
Results support the hypothesis that the anatomical organization of striatal and thalamic neurons expressing EphA7 receptors restricts the topographic distribution of cortical afferents from medial regions of S1 which express high levels of ephrin-A5 (show EFNA5 Antibodies)
EphA4 (show EPHA4 Antibodies)/EphA7 from the pericloacal mesenchyme signal via ephrin B2 (show EFNB2 Antibodies) to mediate nephric duct insertion.
The role of cell-based signaling via the receptor tyrosine kinase (show ERBB3 Antibodies) EphA7 in guiding the extension and maturation of cortical dendrites, was examined.
multi-protein complex comprising ephrinA5, EphA7, and TNFR1 (show TNFRSF1A Antibodies) may constitute a platform for inducing caspase (show CASP3 Antibodies)-dependent apoptotic
Data show that Dlx5 (show DLX5 Antibodies) and Msx2 play a critical role in controlling cranial neural tube morphogenesis by regulating cell adhesion via the ephrinA5 and EphA7 pathway.
This gene belongs to the ephrin receptor subfamily of the protein-tyrosine kinase family. EPH and EPH-related receptors have been implicated in mediating developmental events, particularly in the nervous system. Receptors in the EPH subfamily typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. The ephrin receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands.
ephrin type-A receptor 7
, EPH receptor A7
, ephrin receptor EphA7
, ephrin type-A receptor 7-like
, EPH homology kinase 3
, EPH-like kinase 11
, Eph homology kinase-3
, receptor protein-tyrosine kinase HEK11
, tyrosine-protein kinase receptor EHK-3
, developmental kinase 1
, embryonic brain kinase
, Eph-like receptor tyrosine kinase
, tyrosine-protein kinase receptor CEPHA7